August 14, 2022

Silo Pharma, Inc. Expands Board with Appointment of Dr. Kevin Muoz MD Announces Application ...

NEW YORK , Oct. 06, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTC Pink: SILO), which recently announced its transformation to a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced the appointm